Should we keep our patients with #gout on colchicine indefinitely (if no contraindications/intolerances) for their higher risk of MI/CVD? https://t.co/4bQds3u1oL
Links:
NEJM on Twitter: "In a randomized, placebo-controlled trial involving 4745…
https://twitter.com/nejm/status/1209958245336530944
Dec-28-2019
